Fierce Pharma Asia—Gilead's synthetic lethality deal; A Tokyo biotech IPO; Novo's Ozempic China sales dip

Fierce Pharma Asia—Gilead's synthetic lethality deal; A Tokyo biotech IPO; Novo's Ozempic China sales dip  Fierce Pharma


2 w.
Technology
ID: -3396511352662319437


Similar News expand_more


Science
Economics
Economics
Military
Technology
Science
Science
Technology
Economics
Science
Science
Science
Military
Entertainment
Economics
Science
Technology
Technology
Economics
Technology
Science
Science
Military
Politics
Technology
Economics
Technology
Technology
Crime
Technology
Automotive
Entertainment
Science
Entertainment
Sport
Science
Technology
Economics
Technology
Economics
Entertainment
Science
Science
Technology
Economics
Economics
Technology
Technology
Technology
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down